NCT03280615View on ClinicalTrials.gov

Omega 3 Fatty Acids in Patients With Chronic Renal Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Renal Insufficiency, Chronic

Interventions

DIETARY_SUPPLEMENT

Omega 3 fatty acids

Omega 3 fatty acids will be provided in a dose of 3.7 g/day, that should be enough to rise red blood cell levels of eicosapentanoic and docosahexanoic acids

DIETARY_SUPPLEMENT

Corn oil

Corn oil will be the placebo comparator for omega 3 fatty acids supplement

Trial Locations (1)

Unknown

Institute of Nutrition and Food Technology University of Chile, Santiago

All Listed Sponsors

collaborator

Servicio de Salud Metropolitano Oriente

UNKNOWN

lead

University of Chile

OTHER

NCT03280615 - Omega 3 Fatty Acids in Patients With Chronic Renal Disease | Biotech Hunter | Biotech Hunter